Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I, Open-Label, Single-Center Study to Evaluate the Safety and Dose Linearity of Intramuscular Administration of Midazolam Using

NCT00534378 is registered in ClinicalTrials.gov with U.S. Army Office of the Surgeon General as lead sponsor.

NCT NCT00534378
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00534378 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I, Open-Label, Single-Center Study to Evaluate the Safety and Dose Linearity of Intramuscular Administration of Midazolam Using
Lead sponsor
U.S. Army Office of the Surgeon General
Phase
Phase 1
Overall status
Completed
Start date
July 31, 2006
Completion date
December 31, 2006
Enrollment
39 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

seizures